The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908 · cited 1×
“Again, Craig and colleagues have demonstrated this convincingl”
BackgroundPharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model
Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S., & Craig, W. A. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.4.831 · Cited by 720
Estimation of population characteristics of pharmacokinetic parameters from routine clinical data
Sheiner, L. B., Rosenberg, B., & Marathe, V. V. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061728 · Cited by 700
Pharmacodynamics of Levofloxacin: A New Paradigm for Early Clinical Trials
Preston, S. L. (1998) · JAMA · doi:10.1001/jama.279.2.125 · Cited by 589
Craig, W. A. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00065-5 · Cited by 556
Forecasting individual pharmacokinetics
Sheiner, L. B., Beal, S. L., Rosenberg, B., et al. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979263294 · Cited by 446
Drusano, G. L., Johnson, D. E., Rosen, M., & Standiford, H. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.483 · Cited by 426
Self-citationOptimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria
Kashuba, A. D. M., Nafziger, A. N., Drusano, G. L., & Bertino, J. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.623 · Cited by 380
Self-citationPrevention of Resistance: A Goal for Dose Selection for Antimicrobial Agents
Drusano, G. L. (2003) · Clinical Infectious Diseases · doi:10.1086/344653 · Cited by 356
Self-citationContinuous infusion of beta-lactam antibiotics
Craig, W. A., & Ebert, S. C. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2577 · Cited by 338
Optimal sampling times for pharmacokinetic experiments
D'Argenio, D. Z. (1981) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01070904 · Cited by 324
Craig, W. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321854 · Cited by 318
Ambrose, P. G., Grasela, D. M., Grasela, T. H., Passarell, J., Mayer, H. B., & Pierce, P. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2793-2797.2001 · Cited by 299
Pharmacodynamics of cefepime in patients with Gram-negative infections
Tam, V. H. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf130 · Cited by 262
Drusano, G. L., Preston, S. L., Fowler, C., Corrado, M., Weisinger, B., & Kahn, J. (2004) · The Journal of Infectious Diseases · doi:10.1086/383320 · Cited by 245
Self-citationDrusano, G. L., Preston, S. L., Hardalo, C., Hare, R., Banfield, C., Andes, D., Vesga, O., & Craig, W. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.13-22.2001 · Cited by 243
Self-citationFeldman, C., Kassel, M., Cantrell, J., Kaka, S., Morar, R., Goolam Mahomed, A., & Philips, J. (1999) · European Respiratory Journal · doi:10.1183/09031936.99.13354699 · Cited by 242
Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections
Craig, W. A., Redington, J., & Ebert, S. C. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.suppl_c.29 · Cited by 238
Jumbe, N., Louie, A., Leary, R., Liu, W., Deziel, M. R., Tam, V. H., Bachhawat, R., Freeman, C., Kahn, J. B., Bush, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16814 · Cited by 238
Self-citationJumbe, N., Louie, A., Leary, R., Liu, W., Deziel, M. R., Tam, V. H., Bachhawat, R., Freeman, C., Kahn, J. B., Bush, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316814 · Cited by 236
Self-citationEagle, H., Fleischman, R., & Levy, M. (1953) · New England Journal of Medicine · doi:10.1056/nejm195303192481201 · Cited by 230
Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses
Chien, S. C., Rogge, M. C., Gisclon, L. G., Curtin, C., Wong, F., Natarajan, J., Williams, R. R., Fowler, C. L., Cheung, W. K., & Chow, A. T. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2256 · Cited by 217
Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection Models
Andes, D. R., & Craig, W. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1665-1670.2002 · Cited by 154
Effect of protein binding on antibiotic activity in vivo
Merrikin, D. J., Briant, J., & Rolinson, G. N. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/11.3.233 · Cited by 147
Forrest, A., Chodosh, S., Amantea, M., Collins, D. A., & Schentag, J. J. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.suppl_1.45 · Cited by 137
THE SLOW RECOVERY OF BACTERIA FROM THE TOXIC EFFECTS OF PENICILLIN
Eagle, H., & Musselman, A. D. (1949) · Journal of Bacteriology · doi:10.1128/jb.58.4.475-490.1949 · Cited by 129
Continuous Infusion of ??-Lactam Antibiotics
MacGowan, A. P., & Bowker, K. E. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835050-00004 · Cited by 127
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs
Mouton, J. W., Dudley, M. N., Cars, O., Derendorf, H., & Drusano, G. L. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00031-6 · Cited by 122
Self-citationPreston, S. L., Drusano, G. L., Berman, A. L., Fowler, C. L., Chow, A. T., Dornseif, B. E., Reichl, V., Natarajan, J., Wong, F. A., & Corrado, M. L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1098 · Cited by 117
Self-citationMallet, A., Mentré, F., Steimer, J., et al. (1988) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01062140 · Cited by 94
Chow, A. T., Fowler, C. L., Williams, R. R., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2122-2125.2001 · Cited by 90
D’Argenio, D. Z. (1990) · Mathematical Biosciences · doi:10.1016/0025-5564(90)90141-k · Cited by 82
Bilello, J. A., Bilello, P., Stellrecht, K. A., Leonard, J. M., Norbeck, D. W., Kempf, D. J., Robins, T., & Drusano, G. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1491 · Cited by 78
Self-citationPharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro
Odenholt-Tornqvist, I., Löwdin, E., & Cars, O. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1834 · Cited by 72
In-vitro evaluation of ampicillin/brobactam and comparison with other β-lactam antibiotics
Melchior, N. H., & Keiding, J. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.1.29 · Cited by 71
Drusano, G. L., Bilello, J. A., Stein, D. S., Nessly, M. L., Meibohm, A. R., Emini, E. A., Deutsch, P., Condra, J. H., Chodakewitz, J., & Holder, D. (1998) · The Journal of Infectious Diseases · doi:10.1086/515631 · Cited by 64
Self-citationIntegration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model
Flückiger, U. M., Segessenmann, C., & Gerber, A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1905 · Cited by 62
Combined therapy with zidovudine and L-697,661 in primary HIV infection
Perrin, L., Rakik, A., Yerly, S., et al. (1996) · AIDS · doi:10.1097/00002030-199609000-00009 · Cited by 56
Drusano, G. L., Bilello, J. A., Preston, S. L., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/319281 · Cited by 51
Self-citationWilliamson, R., & Tomasz, A. (1985) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1985.tb09126.x · Cited by 50
Bacterial Colonization of Endotracheal Tubes in Intubated Neonates
Friedland, D. R., Rothschild, M. A., Delgado, M., et al. (2001) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.127.5.525 · Cited by 39
Tod, M., & Rocchisani, J.-M. (1996) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(96)01721-x · Cited by 38
Optimal Sampling Schedule Design for Populations of Patients
Tam, V. H., Preston, S. L., & Drusano, G. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2888-2891.2003 · Cited by 35
Self-citationDrusano, G. L., Moore, K. H. P., Kleim, J. P., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.913-916.2002 · Cited by 24
Self-citationDrusano, G. L., Aweeka, F. T., Gambertoglio, J. G., et al. (1996) · PubMed · Cited by 13
Self-citationProceedings. 17th IEEE Symposium on Computer-Based Medical Systems
(2004) · doi:10.1109/cbms.2004 · Cited by 11
Dudley, M. N., & Ambrose, P. G. (2002) · Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy · Cited by 3
Research works printed but not linked: 3
- Andes, D. & Craig, W. A. Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models. Antimicrob. Agents Chemother. 46, 1665–1670 (2002). · DOI
- Ambrose, P. G., Craig, W. A., Bhavnani, B. M. & Dudley, M. N. Pharmacodynamic comparisons of different dosing regimens of penicillin G against penicillin-susceptible and -resistant pneumococci. Abstract A-635, 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California (2002).
- Drusano, G. L. et al. The relationship between fluoroquinolone AUC/MIC ratio and the probability of eradication in patients with nosocomial pneumonia. J. Infect. Dis. (in the press).
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795
Solomkin, J. S., Mazuski, J. E., Bradley, J. S., Rodvold, K. A., Goldstein, E. J. C., Baron, E. J., O'Neill, P. J., Chow, A. W., Dellinger, E. P., Eachempati, S. R., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649554 · Cited by 1,558
Rybak, M. J., Le, J., Lodise, T. P., Levine, D. P., Bradley, J. S., Liu, C., Mueller, B. A., Pai, M. P., Wong-Beringer, A., Rotschafer, J. C., et al. (2020) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaa036 · Cited by 1,202
Photopharmacology: Beyond Proof of Principle
Velema, W. A., Szymanski, W., & Feringa, B. L. (2014) · Journal of the American Chemical Society · doi:10.1021/ja413063e · Cited by 1,178
Metadata
- Authors
- Drusano, G. L.
- Corresponding author
- Drusano, George L.
- ORCID
- Drusano, George L.
- Venue
- Nature Reviews Microbiology
- Published
- 2004-04
- Volume
- 2
- Issue
- 4
- Pages
- 289-300
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2079691262
- Semantic Scholar
- e530a1cbf47f0acf177ef31bf45c83bfc7ff3b23
- Cited by
- 930
- References
- 48
- Citations by year
- 2026: 41 · 2025: 32 · 2024: 35 · 2023: 40 · 2022: 40 · 2021: 57 · 2020: 56 · 2019: 46 · 2018: 48 · 2017: 55 · 2016: 57 · 2015: 41 · 2014: 56 · 2013: 41 · 2012: 49
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antimicrobial pharmacodynamics, drug exposure, bactericidal activity, pharmacodynamic modeling, antimicrobial resistance, anti-infective therapy, drug toxicity
- MeSH terms
- Anti-Bacterial Agents, Bacterial Infections, Biological Availability, Dose-Response Relationship, Drug, Humans, Microbial Sensitivity Tests, Area Under Curve, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.